Radiopharma CDMO Nucleus lays out plan to triple manufacturing capacity, add 100 jobs

Two years after emerging with its initial funding round, CDMO Nucleus RadioPharma is going bicoastal, revealing expansions at two sites that the company believes will "significantly improve” market access to the promising cancer treatments.